Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review

  • ID: 4372867
  • SWOT Analysis
  • 48 pages
  • GlobalData
  • Cipla Inc
1 of 5

FEATURED COMPANIES

  • Aurobindo Pharma Ltd
  • Biocon Ltd
  • Cadila Healthcare Ltd
  • Claris Lifesciences Ltd
  • Coral Laboratories Ltd.
  • Elder Pharmaceuticals Ltd
  • MORE
Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Cipla Ltd (Cipla) is a global pharmaceutical company which focuses on providing high quality affordable medicines. It researches, develops, manufactures and commercializes a wide range of pharmaceutical products including active pharmaceutical ingredients (APIs), formulations and animal healthcare products. The company also offers over-the-counter (OTC) products and a range of inhalation medications and devices. Cipla provides pharmaceutical products across various therapeutic areas including cardiovascular, children's health, dermatology and cosmetology, diabetes, hepatitis infectious diseases, neurosciences and oncology, among others. It has presence in India, South Africa, the US and other emerging markets in the world. Cipla is headquartered in Mumbai, Maharashtra, India.

Cipla Ltd Key Recent Developments

Jun 20,2017: American Cancer Society and Clinton Health Access Initiative Announce Collaborations with Pfizer and Cipla to Increase Access to Lifesaving Cancer Treatment in Africa
May 25,2017: Cipla announces Q4 & FY 17 results Continued strong performance across key markets
Feb 17,2017: Cipla launches Hepatitis B vaccine in India
Feb 08,2017: Cipla Updates Appoints Mr. Mital Sanghvi To Senior Business Finance Role
Jan 09,2017: Cipla appoints Peter Lankau as an Independent Director on its Board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aurobindo Pharma Ltd
  • Biocon Ltd
  • Cadila Healthcare Ltd
  • Claris Lifesciences Ltd
  • Coral Laboratories Ltd.
  • Elder Pharmaceuticals Ltd
  • MORE
Section 1 - About the Company
  • Cipla Ltd - Key Facts
  • Cipla Ltd - Key Employees
  • Cipla Ltd - Key Employee Biographies
  • Cipla Ltd - Major Products and Services
  • Cipla Ltd - History
  • Cipla Ltd - Company Statement
  • Cipla Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Cipla Ltd - Business Description
  • Cipla Ltd - Corporate Strategy
  • Cipla Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Cipla Ltd - Strengths
  • Cipla Ltd - Weaknesses
  • Cipla Ltd - Opportunities
  • Cipla Ltd - Threats
  • Cipla Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Cipla Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 20, 2017: American Cancer Society and Clinton Health Access Initiative Announce Collaborations with Pfizer and Cipla to Increase Access to Lifesaving Cancer Treatment in Africa
  • May 25, 2017: Cipla announces Q4 & FY 17 results Continued strong performance across key markets
  • Feb 17, 2017: Cipla launches Hepatitis B vaccine in India
  • Feb 08, 2017: Cipla Updates Appoints Mr. Mital Sanghvi To Senior Business Finance Role
  • Jan 09, 2017: Cipla appoints Peter Lankau as an Independent Director on its Board
  • Nov 29, 2016: Cipla appoints Ireena Vittal as an Independent Director on its Board
  • Nov 09, 2016: Cipla announces Q2 FY17 results - Improved profitability in base business & Strengthened R&D pipeline
  • Oct 12, 2016: Cipla Receives EIR from the US FDA for its Indore facility
  • Sep 30, 2016: Cipla receives four FDA observations for three facilities
  • Sep 30, 2016: Clarification sought from Cipla
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Cipla Ltd, Key Facts
  • Cipla Ltd, Key Employees
  • Cipla Ltd, Key Employee Biographies
  • Cipla Ltd, Major Products and Services
  • Cipla Ltd, History
  • Cipla Ltd, Subsidiaries
  • Cipla Ltd, Key Competitors
  • Cipla Ltd, Ratios based on current share price
  • Cipla Ltd, Annual Ratios
  • Cipla Ltd, Annual Ratios (Cont...1)
  • Cipla Ltd, Annual Ratios (Cont...2)
  • Cipla Ltd, Interim Ratios
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Cipla Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Cipla Ltd, Performance Chart (2013 - 2017)
  • Cipla Ltd, Ratio Charts
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Torrent Pharmaceuticals Ltd
  • Lupin Ltd
  • IPCA Laboratories Ltd
  • Hikal Ltd
  • Elysium Pharmaceuticals Ltd
  • Elder Pharmaceuticals Ltd
  • Dr. Reddy's Laboratories Ltd
  • Coral Laboratories Ltd.
  • Claris Lifesciences Ltd
  • Cadila Healthcare Ltd
  • Biocon Ltd
  • Aurobindo Pharma Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll